期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Recrystallization texture development in rare-earth(RE)-doped non-oriented silicon steel 被引量:9
1
作者 Zheng-hua He yu-hui sha +3 位作者 Yong-kuang Gao Song-tao Chang Fang Zha Liang Zuo 《Journal of Iron and Steel Research International》 SCIE EI CAS CSCD 2020年第11期1339-1346,共8页
High-grade non-oriented silicon steel with higher permeability and lower core loss has become the pursed target with the rapid developnient of electrical machines.The effects of rare-earth(RE)element on recrystallizat... High-grade non-oriented silicon steel with higher permeability and lower core loss has become the pursed target with the rapid developnient of electrical machines.The effects of rare-earth(RE)element on recrystallization texture in RE-doped Fe-3.1 wt.%Si-1.2 wt.%Al non-oriented silicon steel were investigated by macro-and micro-texture analyses.Nonlinear variation of recrystallization texture with RE element content was observed.In the competition among main recrystallization texture components,favorable{113}<361>and X fiber(<001>//ND)are strengthened and unfavorable y fiber is evidently decreased by the addition of RE element,whereas the effect of RE element is reversed by excess RE element.The recrystallization texture development is determined by RE-affected nucleation and grain growth in terms of grain boundary migration related to segregation and inclusion.The properly inhibited grain boundary mobility can promote favorable recrystallization texture by the improved nucleation and efficient grain growth. 展开更多
关键词 Non-oriented silicon steel TEXTURE Rare-earth element Grain boundary SEGREGATION
原文传递
3-Bromopyruvate alleviates the development of monocrotalineinduced rat pulmonary arterial hypertension by decreasing aerobic glycolysis,inducing apoptosis,and suppressing inflammation 被引量:3
2
作者 Jie Liu Wang Wang +3 位作者 Lei Wang Xian-Mei Qi yu-hui sha Ting Yang 《Chinese Medical Journal》 SCIE CAS CSCD 2020年第1期49-60,共12页
Background:Pulmonary arterial hypertension(PH)is a progressive disease with limited therapeutic options,ultimately leading to right heart failure and death.Recent findings indicate the role of the Warburg effect(aerob... Background:Pulmonary arterial hypertension(PH)is a progressive disease with limited therapeutic options,ultimately leading to right heart failure and death.Recent findings indicate the role of the Warburg effect(aerobic glycolysis)in the development of PH.However,the effect of the glycolysis inhibitor 3-bromopyruvate(3-BrPA)on the pathogenesis of PH has not been well investigated.This study aimed to determine whether 3-BrPA inhibits PH and its possible mechanism.Methods:PH was induced in adult Sprague-Dawley rats by a single intraperitoneal injection of monocrotaline(MCT).3-BrPA,or phosphate-buffered saline(PBS)was administered via intraperitoneal injection every other day from the first day of MCT-injection to 4 weeks of follow-up,and indices such as right ventricular systolic pressure(RVSP),right ventricular hypertrophy index(RVHI),pulmonary arteriolar remodeling indicated by percent media thickness(%MT),lactate levels and glucose consumption,were evaluated.Pulmonary arteriolar remodeling and right ventricular hypertrophy were observed in hematoxylin-eosin-stained lung sections.Western blotting,immunohistochemistry,and/or immunofluorescence analyses were used to measure the expression of relevant proteins.A cytochrome C release apoptosis assay and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling staining were used to measure cell apoptosis.Results:MCT-induced PH showed a significant increase in glucose consumption(0 vs.4 weeks:0.87±0.23 vs.2.94±0.47,P=0.0042)and lactate production(0 vs.4 weeks:4.19±0.34 vs.8.06±0.67,P=0.0004).Treatment with 3-BrPA resulted in a concomitant reduction in glucose consumption(1.10±0.35 vs.3.25±0.47,P=0.0063),lactate production(5.09±0.55 vs.8.06±0.67,P=0.0065),MCT-induced increase in RVSP(39.70±2.94 vs.58.85±2.32,P=0.0004),pulmonary vascular remodeling(%MT,43.45%±1.41%vs.63.66%±1.78%,P<0.0001),and right ventricular hypertrophy(RVHI,38.57%±2.69%vs.62.61%±1.57%,P<0.0001)when compared with those of the PBS-treated group.3-BrPA,a hexokinase 2 inhibitor,exerted its beneficial effect on PH by decreasing aerobic glycolysis and was also associated with inhibiting the expression of glucose transporter protein-1,inducing apoptosis,and suppressing inflammation.Conclusions:3-BrPA might have a potential beneficial effect on the PH treatment. 展开更多
关键词 Pulmonary arterial hypertension MONOCROTALINE 3-Bromopyruvate Aerobic glycolysis
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部